Viral respiratory infections are the major cause of asthma exacerbations and, in some situations, may also contribute to the overall pathogenesis of asthma. It is the overall goal of our Asthma and Allergic Diseases Research Center (AADRC) to establish the mechanisms by which respiratory viruses can contribute to the pathogenesis of asthma. Central to this goal, it remains our hypothesis that a major mechanism in virus-induced asthma is the ability of respiratory viruses to cause or enhance airway inflammation. This occurs, it is believed, through the generation of proinflammatory cytokines and chemokines from resident airway cells, i.e., epithelial cells and airway macrophages, and the subsequent recruitment and activation of leukocytes, primarily neutrophils, in the airway to cause acute and, in some cases, persistent inflammation. In addition, it is hypothesized that a major mechanism of asthma pathogenesis and exacerbations from viral respiratory infections is a cytokine dysregulation, which is characterized by diminished T helper (Th)1 interferon (IFN)-gamma activity and enhanced Th2 responsiveness. To accomplish this overall goal, five areas of investigation are proposed. Project 1 will examine the hypothesis that diminished IFN-gamma production is a characteristic of some asthma patients, and this variant in cytokine generation enhances the severity of the infection, the generation of inflammatory mediators, and, consequently, an exacerbation of asthma in humans. Project 2 will determine the mechanisms responsible for IFN-gamma dysregulation in weaning Brown Norway rats by investigating the cellular, molecular, and developmental regulation of IFN-gamma by natural killer (NK) cells, CD8+ T cells, and CD4+ T cells. Project 3 will determine the intracellular signal transduction events in macrophages that occur with RV activation and how those signaling molecules regulate the generation of cytokines and experimental RV inoculation. Project 4 will test the hypothesis that RV infection of epithelial cells promotes interleukin (IL)-8 production by stabilizing IL-8 mRNA via MAP kinase signaling leading to interaction with AUUUA-binding proteins. Project 5 will characterize how products of viral respiratory infections, i.e., IL-8, modulate neutrophil function and how these consequences contribute to the generation of airway inflammation. A Core for Virology will provide virus preparations. It is proposed that these collaborative studies will provide new insight into mechanisms of respiratory-virus-induced asthma, the possible role of diminished IFN-gamma production in this process, and possibilities for new treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI050500-02
Application #
6534368
Study Section
Special Emphasis Panel (ZAI1-NBS-I (M3))
Program Officer
Adams, Ken
Project Start
2001-09-07
Project End
2006-06-30
Budget Start
2002-09-01
Budget End
2003-06-30
Support Year
2
Fiscal Year
2002
Total Cost
$976,692
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Ludka-Gaulke, Tiffany; Ghera, Princy; Waring, Stephen C et al. (2018) Farm exposure in early childhood is associated with a lower risk of severe respiratory illnesses. J Allergy Clin Immunol 141:454-456.e4
Gavala, Monica L; Bertics, Paul J; Gern, James E (2011) Rhinoviruses, allergic inflammation, and asthma. Immunol Rev 242:69-90
Hill, Lindsay M; Gavala, Monica L; Lenertz, Lisa Y et al. (2010) Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptor X7-dependent vascular endothelial growth factor release from primary human monocytes. J Immunol 185:3028-34
Gern, James E (2010) The ABCs of rhinoviruses, wheezing, and asthma. J Virol 84:7418-26
Korpi-Steiner, N L; Valkenaar, S M; Bates, M E et al. (2010) Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin Exp Allergy 40:1203-13
Lemanske Jr, Robert F; Busse, William W (2010) Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol 125:S95-102
DeMore, Jennifer P; Weisshaar, Elizabeth H; Vrtis, Rose F et al. (2009) Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol 124:245-52, 252.e1-3
Rosenthal, Louis A; Amineva, Svetlana P; Szakaly, Renee J et al. (2009) A rat model of picornavirus-induced airway infection and inflammation. Virol J 6:122
Denlinger, Loren C; Shi, Lei; Guadarrama, Arturo et al. (2009) Attenuated P2X7 pore function as a risk factor for virus-induced loss of asthma control. Am J Respir Crit Care Med 179:265-70
Sorkness, Ronald L; Gonzalez-Fernandez, Guillermo; Billmeyer, Erin E et al. (2008) The asthma index: a continuous variable to characterize exacerbations of asthma. J Allergy Clin Immunol 122:838-40

Showing the most recent 10 out of 34 publications